Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)

dc.contributor.authorMak, Joyce W. Y.
dc.contributor.authorSun, Yang
dc.contributor.authorLimsrivilai, Julajak
dc.contributor.authorAbdullah, Murdani
dc.contributor.authorKaibullayeva, Jamilya
dc.contributor.authorBalderramo, Domingo
dc.contributor.authorVergara, Beatriz I.
dc.contributor.authorPaudel, Mukesh S.
dc.contributor.authorBanerjee, Rupa
dc.contributor.authorHilmi, Ida
dc.contributor.authorAli, Raja A. R.
dc.contributor.authorWei, Shu C.
dc.contributor.authorNg, Ka K.
dc.contributor.authorAltuwaijri, Mansour
dc.contributor.authorKelly, Paul
dc.contributor.authorYamamoto-Furusho, Jesus K.
dc.contributor.authorKotze, Paulo G.
dc.contributor.authorAhuja, Vineet
dc.contributor.authorChong, Vui H.
dc.contributor.authorDao, Hang V.
dc.contributor.authorAbbey, Yvonne
dc.contributor.authorChing, Jessica Y. L.
dc.contributor.authorHo, Agnes
dc.contributor.authorChan, Alicia K. W.
dc.contributor.authorBernstein, Charles N.
dc.contributor.authorGearry, Richard B.
dc.contributor.authorAbreu, Maria
dc.contributor.authorRubin, David T.
dc.contributor.authorDotan, Iris
dc.contributor.authorHracs, Lindsay
dc.contributor.authorKaplan, Gilaad G.
dc.contributor.authorNg, Siew C.
dc.date.accessioned2023-05-28T00:03:09Z
dc.date.available2023-05-28T00:03:09Z
dc.date.issued2023-05-25
dc.date.updated2023-05-28T00:03:09Z
dc.description.abstractAbstract Background There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. Methods Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. Results Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. Conclusions The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries.
dc.identifier.citationBMC Medical Research Methodology. 2023 May 25;23(1):129
dc.identifier.urihttps://doi.org/10.1186/s12874-023-01944-2
dc.identifier.urihttps://hdl.handle.net/1880/116576
dc.identifier.urihttps://dx.doi.org/10.11575/PRISM/41419
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleDevelopment of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12874_2023_Article_1944.pdf
Size:
797.61 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.25 KB
Format:
Item-specific license agreed upon to submission
Description: